FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+6.28%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$365M
AUM Growth
+$365M
(+15%)
Cap. Flow
+$43.5M
Cap. Flow
% of AUM
11.92%
Top 10 Holdings %
Top 10 Hldgs %
51.36%
Holding
54
New
2
Increased
25
Reduced
15
Closed
2
Top Buys
| 1 |
Xencor
XNCR
|
$14.1M |
| 2 |
NeoGenomics
NEO
|
$12.8M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$10.5M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$6.66M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$6.63M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$9.04M |
| 2 |
MDCO
Medicines Co
MDCO
|
$8.16M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$5.93M |
| 4 |
MacroGenics
MGNX
|
$1.48M |
| 5 |
STRM
Streamline Health Solutions
STRM
|
$652K |
Sector Composition
| 1 | Healthcare | 84.02% |
| 2 | Communication Services | 4.08% |
| 3 | Energy | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bio-Techne
TECH
$8.5B
| $4.93M | 1.35% | 38,071 -583 | -2% | -$75.5K |
|
|
KTWO
27
DELISTED
K2M Group Holdings, Inc
KTWO
| $4.87M | 1.34% | 270,758 -4,415 | -2% | -$79.5K |
|
28
HealthStream
HSTM
$832M
| $4.85M | 1.33% | 209,587 +10,344 | +5% | +$240K |
|
|
NXTM
29
DELISTED
NxStage Medical Inc.
NXTM
| $4.67M | 1.28% | 192,670 +9,078 | +5% | +$220K |
|
|
LHCG
30
DELISTED
LHC Group LLC
LHCG
| $4.21M | 1.16% | 68,807 +4,135 | +6% | +$253K |
|
31
Vertex Pharmaceuticals
VRTX
$100B
| $3.46M | 0.95% | 23,057 -364 | -2% | -$54.5K |
|
32
BioMarin Pharmaceuticals
BMRN
$11.2B
| $2.78M | 0.76% | 31,213 -689 | -2% | -$61.4K |
|
33
IRIDEX
IRIX
$22.8M
| $2.42M | 0.66% | 317,799 +79,004 | +33% | +$602K |
|
|
STRM
34
DELISTED
Streamline Health Solutions
STRM
| $2.32M | 0.64% | 1,375,044 -385,662 | -22% | -$652K |
|
35
iShares Biotechnology ETF
IBB
$5.6B
| $2.27M | 0.62% | 21,291 +14,194 | +200% | +$1.52M |
|
36
Ionis Pharmaceuticals
IONS
$6.79B
| $2.11M | 0.58% | 41,847 -664 | -2% | -$33.4K |
|
|
ENZ
37
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.93M | 0.53% | 237,054 +11,438 | +5% | +$93.2K |
|
|
XLVS
38
DELISTED
POWERSHARES S&P SMALLCAP HEALTH CARE PORTFOLIO
XLVS
| $1.7M | 0.47% | 17,285 | – | – |
|
39
Alkermes
ALKS
$4.78B
| $1.62M | 0.44% | 29,533 -554 | -2% | -$30.3K |
|
40
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $1.51M | 0.41% | 18,241 | – | – |
|
41
LeMaitre Vascular
LMAT
$2.16B
| $1.47M | 0.4% | 46,119 -697 | -1% | -$22.2K |
|
|
CELG
42
DELISTED
Celgene Corp
CELG
| $1.41M | 0.39% | 13,512 -344 | -2% | -$35.9K |
|
|
43
MacroGenics
MGNX
$112M
| $1.4M | 0.38% | 73,558 -78,112 | -52% | -$1.48M |
|
44
iShares US Medical Devices ETF
IHI
$4.33B
| $1.32M | 0.36% | 7,580 | – | – |
|
45
SPDR S&P Biotech ETF
XBI
$5.07B
| $806K | 0.22% | 9,499 | – | – |
|
46
AbbVie
ABBV
$372B
| $402K | 0.11% | 4,159 | – | – |
|
47
Pfizer
PFE
$141B
| $310K | 0.09% | 8,558 | – | – |
|
48
Johnson & Johnson
JNJ
$427B
| $305K | 0.08% | 2,183 | – | – |
|
|
DYNT
49
DELISTED
Dynatronics Corp
DYNT
| $301K | 0.08% | 104,379 +2,355 | +2% | +$6.79K |
|
50
Novartis
NVS
$245B
| $300K | 0.08% | 3,572 | – | – |
|